MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-156

  1. 12,393 Posts.
    lightbulb Created with Sketch. 3370
    Really - are we doing this again?

    Let's not forget about this study - did it meet its endpoints? https://clinicaltrials.gov/study/NCT02336230

    How about this guy?
    He's just a punter right? He doesn't know anything about the science, GVHD and he doesn't have a reputation to uphold?
    According to you - These guys at BMT CTN are just throwing good resources (= $$$) at a trial - that has minimal chance of success. Just because SI twisted their arms - go figure!

    https://hotcopper.com.au/data/attachments/5761/5761751-04cd6c0febd815177ddfa27546d83d12.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.